Aneurysm is characterized by balloon-like expansion of the arterial wall and eventual rupture of the aorta. The pathogenesis of aneurysm is associated with the degradation of matrix proteins by matrix metalloproteinases (MMPs) produced by activated macrophages. Although aneurysm is associated with significant mortality and morbidity, surgical intervention is the only proven treatment strategy. Therefore, development of therapeutic agents for aneurysm is greatly anticipated. Here, we demonstrated the protective effects of the major isoflavone puerarin, which is found in kudzu roots and vines. Aneurysms were surgically induced in ten-wk-old male mice using CaPO4. Subsequently, animals were intraperitoneally injected daily with puerarin at 2.5 mg/kg body weight or with vehicle alone for 2 wk. CaPO4-induced aneurysm was significantly suppressed by puerarin administration. In subsequent macrophage activation assays using Tumor necrosis factor (TNF␣) and CaPO4 crystals in vitro, puerarin decreased Mmp9 mRNA expression and secreted protein levels. Moreover, induction of IB, ERK, and p38 phosphorylation by TNF␣ and CaPO4 in macrophages was suppressed by puerarin treatments. Finally, puerarin attenuated reactive oxygen species production, following induction by TNF␣ and CaPO4. Taken together, the present data demonstrate that puerarin suppresses macrophage activation by inhibiting IB, ERK, and p38 activity and reactive oxygen species production in a CaPO4-induced mouse model of aneurysm.
Aneurysms are caused by balloon-like expansions of aortic walls and occur predominantly in men over 65 y of age (1) . Progressive weakening of the artery wall can lead to rupture if left untreated and carries a high risk of mortality (2) . The pathogenesis of aneurysm is closely associated with chronic inflammation of the arterial wall, local activation of proteinases, and degradation of matrix proteins by matrix metalloproteinases (MMPs) produced by activated macrophages (3, 4) . Currently, surgical interventions include open repair or endovascular stent graft placement. Although these procedures are the only proven treatments for aneurysm, they are associated with significant morbidity and mortality risks, warranting the urgent development of alternative therapeutic strategies.
Puerarin (daidzein-8-C-glycoside) is an isoflavone found in roots and vines of the kudzu plant (Pueraria lobata) and has been used widely as a traditional Chinese herbal medicine for various diseases (5) (6) (7) . The structural formula of puerarin is shown in Fig. 1 . Several studies report antioxidant and anti-inflammatory effects of puerarin in mice. Among these, puerarin reportedly protects against CCl 4-induced oxidative stress and inflammation in the kidneys via the ERK/Nrf2/ARE pathway (8) and against nickel-induced TLR4/p38/ CREB associated oxidative stress and inflammation in the liver (9) . However, the effects of puerarin on the formation of aneurysms have not been extensively studied.
In this study, we investigated the protective effects of puerarin against CaPO 4-induced aneurysms in mice and showed that puerarin suppresses macrophage activation via antioxidant mechanisms.
MATERIALS AND METHODS

Materials.
Tumor necrosis factor (TNF␣) was purchased from Peprotech (Rocky Hill, NJ). Puerarin was purchased from Sigma-Aldrich (St. Louis, MO). All reagents and chemicals were of laboratory grade.
Cell culture. Murine RAW264.7 monocyte cells were purchased from American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 g/ mL streptomycin. Prior to macrophage activation, cells were plated at 5ϫ10 5 cells per well in 6-well plates and maintained in minimal essential medium alpha (MEM␣) supplemented with 10% charcoal-stripped FBS and antibiotics.
Cell viability assays. RAW264.7 cells (4,000 cells per well) were cultivated in 96-well plates 1 d before treatments and were then cultured with or without TNF␣ and CaPO4 in the presence or absence of puerarin. Subsequently, cells were combined with MTT solution [3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (50 ng/well)] and incubated for 4 h. Acid-isopropanol (0.04 N HCl in isopropanol) and 3% sodium lauryl sulfate were then added and mixed to dissolve reduced MTT crystals (formazan) in the cells, and absorbance was determined at 595 nm with a reference wavelength of 655 nm using a microplate reader.
Generation and treatment of the mouse model of Aneurysm. Ten-week-old male C57BL/6 mice were obtained from the Jackson Laboratory (Bar Harbor, ME). The procedures for creating our CaPO4-induced mouse model of aneurysm were previously described (10) . We applied the procedure for the infrarenal aorta to the carotid artery in this study. Briefly, 0.5-M CaCl2-soaked gauze was applied to the carotid artery in a perivascular manner for 10 min. The gauze was then replaced with phosphate buffered saline (PBS)-soaked gauze for 5 min, and the incised area was sutured. The diameter of the artery at the time of the initial surgery and sacrifice was measured with an electronic digital caliper (VWR International, West Chester, PA). All animal procedures were conducted in accordance with experimental protocols that were approved by the Institutional Animal Care and Use Committee at the University of Wisconsin, Madison (Protocol M02394).
Histological and immunohistochemical analyses. Murine carotid artery tissues were fixed in 4% paraformaldehyde (PFA) overnight. Samples were then embedded with optical cutting temperature compound (Sakura Tissue-Tek, Alphen aan den Rijn, the Netherlands) and were frozen, and were then sectioned at a thickness of 6 m. Histological analyses were performed with hematoxylin and eosin (HE) stained sections using a light microscope (Olympus BH-2; Olympus, Tokyo, Japan). Immunofluorescent staining was performed using rat anti-MOMA-2 (ab33451, Abcam Cambridge, MA) and donkey anti-rat Alexa 488 (Molecular Probes). Nuclei were stained using TO-PRO 3 (Molecular Probes). Sections were visualized under a fluorescence microscope, and digital images were generated using a Nikon A1R Laser Scanning Confocal imaging system with appropriate argon beam lasers.
Western blotting. Proteins from cultured cells were extracted using a radioimmunoprecipitation assay buffer containing a protease inhibitor cocktail (Cell Signaling Technology, Danvers, MA) at 0-4˚C. Subsequently, 20-g lysates were separated on 8-12% polyacrylamide gels in Laemmli sample buffer and were then electrophoretically transferred onto polyvinylidene difluoride membranes. Primary antibodies for rabbit MMP-9 antibody (sc-10737), rabbit p-IB antibody (sc-101713), rabbit IB antibody (sc-371), rabbit ERK antibody (sc-94), rabbit p38 antibody (sc-535), and mouse ␣-Tubulin (sc-23948) antibody were purchased from Santa Cruz Biotechnology (Dallas, TX). Rabbit p-ERK antibody (9101S) and rabbit p-ERK antibody (9101S) were purchased from Cell Signaling Technology. Primary antibodies were detected using a horseradish peroxidaseconjugated secondary antibody and were visualized using an Enhanced Chemiluminescence kit (Thermo Scientific, Rockford, IL) or SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific).
Quantitative real-time PCR. Total RNA was extracted from RAW264.7 cells using an RNeasy Plus Mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Quantitative real-time PCR was performed using SYBR Green dye with a real-time PCR instrument (ABI, Foster City, CA). Primer sequences were as follows: Mmp9: F, 5′-CATTCGCGTGGATAAGGAGT-3′ and R, 5′-GTTCACCTCATGGTCCACCT-3′; Gapdh: F, 5′-TGGTGAAGGTCGGTGTGAAC-3′ and R, 5′-AAT-GAAGGGGTCGTTGATGG-3′. Mmp9 expression levels were normalized to those of Gapdh.
Intracellular reactive oxygen species (ROS) detection. The intracellular ROS level was measured using an OxiSelect Intracellular ROS Assay Kit with green fluorescence (Cell Biolabs, San Diego, CA). T he fluorescent probe 2′,7′-dichlorodihydrofluorescin diacetate (DCFH-DA) incorporated into cells is deacetylated by cellular esterases to non-fluorescent 2′,7′-dichlorodihydrofluorescin (DCFH) and then rapidly oxidized to highly fluorescent 2′,7′-dichlorodihydrofluorescein (DCF) by different kinds of ROS. The fluorescence intensities of DCF were determined using a fluorometric plate reader.
Statistical Analysis. Data are reported as meansϮ standard deviations (SD). Statistical analyses were performed using the GraphPad Prism program version 4.00 (GraphPad Software, Inc., San Diego, CA). Comparisons between groups at single time points were performed using Student's t-tests. Multiple comparisons among treatments were performed using one-way analysis of variance followed by Tukey's range test. For statistical analysis in Fig. 3B , two-way analysis of variance followed by Tukey's test was performed. Differences were considered significant when pϽ0.05. 
RESULTS
Protective effects of puerarin on the formation of CaPO4-induced aneurysms in mice
Puerarin (2.5 mg/kg/d) was administered intraperitoneally for 2 wk. As shown in Fig. 2A and B, puerarin injections significantly suppressed the formation of aneurysms according to fold increases in maximum diameters of the arteries between initial surgery and sacrifice ( Fig. 2B; 1.9Ϯ0.3 vs. 1.5Ϯ0.2; pϽ0.05). Subsequently, we determined whether puerarin suppressed macrophage accumulation. In these experiments, activated monocytes and macrophages were identified according to MOMA-2 expression in immunohistochemical analyses, and were mostly localized in the adventitia of mice with CaPO4-induced aneurysms (Fig.  2C) . Numbers of monocytes and macrophages were markedly decreased in puerarin-injected mice compared with untreated mice controls. These results suggest that puerarin suppresses a CaPO4-induced aneurysm by inhibiting macrophage activation.
Inhibitory effects of puerarin on TNF␣ϩCaPO4-induced macrophage activation
Previously, we demonstrated macrophage activation following treatment with TNF␣ and CaPO4 (11) using MMP9 as a marker of classical macrophage activation in RAW264.7 cells (12, 13) . As shown in Figs. 3A and B, TNF␣ϩCaPO4 treatment significantly increased MMP9 mRNA and protein expression compared with that in non-treated controls. Puerarin treatment dose-dependently suppressed TNF␣ϩCaPO4-induced Mmp9 mRNA expression at 50-200 M but did not affect Mmp9 expression in untreated cells (Fig. 3A) . Relative expression of Mmp9 in cells treated with 100-and 200-M puerarin was significantly lower than that in controls (41.9Ϯ5.7 vs. 31.9Ϯ5.9, pϽ0.05 and 41.9Ϯ5.7 vs. 9.4Ϯ2.0, respectively, pϽ0.01). MMP9 is synthesized as an inactive pro-enzyme (pro-MMP9) and is activated by proteolytic removal of an amino-terminal following secretion into the extracellular space (14) . Thus we next measured the levels of active Mmp9 by Western blotting. The levels of active Mmp9 were decreased after puerarin treatment, following induction by TNF␣ϩCaPO4 (Fig.  3B, 10 .7Ϯ1.0 vs. 7.6Ϯ2.1, pϽ0.05). However, MTT assays revealed no significant differences in cell proliferation among the six study groups (Fig. 3C) . Taken together, these data suggest that puerarin suppresses TNF␣ϩCaPO4-induced macrophage activation without affecting cell viability.
Inhibitory effect of puerarin on the phosphorylation of IB, ERK, and p38 in TNF␣ϩCaPO4-activated macrophages
The transcription factor NF-B plays important roles in macrophage activation (15) . Specifically, translocation of NF-B to the nucleus is followed by phosphorylation, ubiquitination, and proteasomal degradation of IB␣ (16) . In addition, MAPK signaling pathways, including ERK and p38, are activated during oxidative stress and inflammation in macrophages (17, 18). Thus, in the present study, the involvement of NFB and MAPK signaling pathways in puerarin suppression of macrophage activation was investigated using Western blotting. In these experiments, puerarin treatments decreased p-IB, p-ERK, and p38 protein expression in TNF␣ϩCaPO4-activated macrophages (Fig. 4) . These data suggest that suppression of NFB and MAPK signaling is involved in the protective effects of puerarin against macrophage activation.
Inhibitory effects of puerarin on TNF␣ϩCaPO4-induced reactive ROS production
Induction of NFB and MAPK signaling pathways by oxidative stress was diminished in the presence of puerarin. Thus, because Han et al. previously reported radical scavenging activities of puerarin in vitro (19, 20) , we determined intracellular ROS levels in TNF␣ϩCaPO4-activated macrophages. RAW264.7 cells were labeled with the fluorescent probe DCFH-DA, and the cellular fluorescence intensity was measured using a fluorescent spectrophotometer. As shown in Fig. 5 , TNF␣ϩCaPO4 increased intracellular ROS levels by 1.2 fold compared with those in untreated control cells. However, in the presence of puerarin, TNF␣ϩCaPO4-induced intracellular ROS production was abolished (1.2Ϯ0.1 vs. 0.9Ϯ0.1, pϽ0.05). Hence, puerarin may suppress macrophage activation by decreasing ROS levels. . Puerarin pretreatment blocks phosphorylation of IB, ERK, and p38 in TNF␣ϩCaPO4-activated macrophages. IB, ERK, and p38 phosphorylation in RAW264.7 cells after stimulation with TNF␣ϩCaPO4; Cells in DMEM were seeded in 6-well plates at a density of 3ϫ10 5 cells/well. On the following day, cells were preincubated with puerarin for 24 h in MEM-␣ containing 10% cFBS and were then stimulated with TNF␣ϩCaPO4 for indicated times.
DISCUSSION
Isoflavones have several positive effects (21) (22) (23) (24) and are principally found as glycosides bound to sugars in plants (25) . Following oral administration, O-glycoside isoflavones are hydrolyzed by ␤-glucosidase to aglycones (26) . Puerarin has a C-glycoside bond that is resistant to degradation by mouse microflora (27) . Prasain et al. (28) showed that non-metabolized puerarin and a small amount of its glucuronide were predominantly absorbed and detected at the early stage of feeding in the serum of puerarin-fed rats. Moreover, orally administered puerarin was widely distributed in tissues (kidney, liver, lung, pancreas, heart, eye, and brain) of rats (28) (29) (30) , suggesting that puerarin is absorbed into the circulation without deglycosylation or conjugation. In this study, we showed that this unique isoflavone was protective against the formation of aneurysms and inhibited macrophage activation in mice.
Lu et al. showed that dietary phytoestrogen suppressed the formation of aneurysms in male mice (31) using an elastase-induced model of the aneurysm. In the present model of the aneurysm, CaPO4 induces apoptosis of vascular smooth muscle cells with subsequent macrophage infiltration, leading to the formation of aneurysms. This process resembles the pathophysiology of the aneurysm, which proceeds with the destruction of elastin and collagen by MMPs, vascular smooth muscle cell apoptosis/necrosis, and macrophage infiltration through vessel walls (32) .
While arterial aneurysms predominantly occur in the abdominal aorta, we applied CaPO4 to the adventitia of carotid arteries to induce the formation of aneurysms. As well as abdominal aneurysm, by application of CaCl2 to the adventitia of carotid arteries, arterial dilatation was reportedly accompanied by elastin calcification, loss of VSMCs, and marked infiltration of inflammatory cells such as neutrophils, lymphocytes, monocytes, and multinucleated giant cells (33) . Although another group has utilized the carotid artery as a model for aortic aneurysm (34) , possible physiological differences between these anatomical structures make the carotid artery an imperfect model and is a limitation of this study.
Plasma TNF␣ concentrations were reportedly higher in patients with intracranial aneurysms than in agematched healthy controls (35) , and have been shown to play important roles in the pathogenesis of aneurysms (36, 37) . Moreover, vascular calcification deposits comprise hydroxyapatite and other forms of CaPO4 crystals, which have proinflammatory effects and induce apoptosis (10) . Accordingly, we previously reported activation of RAW264.7 macrophages using TNF␣ϩCaPO4 as a model of calcification in aneurysmal aortas. In the present TNF␣ϩCaPO4-activated macrophages, MMP9 mRNA expression and secreted protein levels were elevated but were not increased in the presence of puerarin. When we examined the accumulation of puerarin in RAW264.7 cells by high performance liquid chromatography, the time-dependent accumulation of puerarin in RAW264.7 was observed (data not shown). These results suggest that puerarin is incorporated in macrophages and suppress macrophage activation.
Because isoflavones reportedly act as estrogen mimetics (38, 39) , the protective effects of puerarin may reflect estrogen-like activities. However, our previous experiments showed that uterine atrophy due to estrogen deficiency was unaltered by a puerarin-rich diet in OVX mice (7, 40) . Moreover, although the puerarin aglycone daidzein bound to estrogen receptors, puerarin did not bind estrogen receptors ␣ or ␤ (40). Therefore, the mechanism by which puerarin suppresses the formation of aneurysms may not involve estrogen-like activities.
In this study, we tried to elucidate the mechanism by which puerarin decreases MMP9 expression, although there exist multiple mechanisms underlying this effect. Phosphorylation levels of IB, ERK, and p38 were determined following activation by TNF␣ϩCaPO4. In these experiments, puerarin suppressed phosphorylation of IB, p38, ERK, and JNK, and attenuated reactive oxygen species production. Tobar et al. reported that ROS-NFB acts as the crucial signal in transforming growth factor-␤1-induced MMP-9 expression (41). There are also some reports that the suppression of NF-B and MAPKs activation contribute to decrease MMP9 expression in macrophages (42, 43) . Therefore, we suggest that the effect of puerarin is, at least in part, due to inhibiting IB, ERK, and p38 activity via antioxidant mechanisms.
A single oral administration of puerarin to rats shows rapid clearance from the blood (t1/2ϭ1.7Ϯ0.6 h) and low bioavailability (44) . Thus, in this study, puerarin Fig. 5 . Inhibitory effects of puerarin on TNF␣ϩCaPO4-induced ROS production. Inhibitory effects of puerarin on ROS levels during TNF␣ϩCaPO4-induced macrophage activation; RAW 264.7 cells were seeded in 96-well plates (4,000 cells/well) containing DMEM and were incubated for 24 h. Subsequently, the culture medium was replaced with MEM-␣ containing 10% cFBS and puerarin. After 48 h, cells were gently washed twice with PBS, and dichloro-dihydro-fluorescein diacetate (DCFH-DA) was added and incubated for 60 min at 37˚C in the dark. After washing cells twice with PBS, the fluorescence intensities of 2′,7′-dichlorofluorescein (DCF) were determined using a fluorometric plate reader at an excitation wavelength of 504 nm and emission wavelength of 524 nm. Data are presented as meansϮSD; * pϽ0.05.
was intraperitoneally administrated to mice to enhance its bioavailability. However, 100 M or larger concentrations of puerarin required for in vitro assay were shown to be higher than the approximately 20 M concentrations of puerarin in blood when puerarin was intraperitoneally administered to mice (45) . The macrophage activation assay using RAW264.7 might not reflect the in vivo response of macrophages. Therefore, we propose further studies using bone marrow-derived primary cell culture to resolve the differences between in vivo and in vitro.
In summary, the present data show inhibitory effects of puerarin on the formation of aneurysms in mice and suppression of macrophage activation in arterial walls. Moreover, in vitro assays showed inhibitory effects of puerarin on macrophage activation, likely reflecting antioxidant activities. Although further research is required, the present study warrants consideration of puerarin as a novel therapeutic agent for an aneurysm.
